GC0000096A - Treatment of female sexual dysfunction. - Google Patents

Treatment of female sexual dysfunction.

Info

Publication number
GC0000096A
GC0000096A GCP199973A GC0000096A GC 0000096 A GC0000096 A GC 0000096A GC P199973 A GCP199973 A GC P199973A GC 0000096 A GC0000096 A GC 0000096A
Authority
GC
Cooperation Council for the Arab states of the Gulf
Prior art keywords
treatment
sexual dysfunction
female sexual
female
dysfunction
Prior art date
Application number
Other languages
English (en)
Inventor
Ragab Al-Rashidy
Bruce Ronsen
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Application granted granted Critical
Publication of GC0000096A publication Critical patent/GC0000096A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GCP199973 1998-01-30 1999-01-31 Treatment of female sexual dysfunction. GC0000096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/016,252 US5945117A (en) 1998-01-30 1998-01-30 Treatment of female sexual dysfunction

Publications (1)

Publication Number Publication Date
GC0000096A true GC0000096A (en) 2005-06-29

Family

ID=21776169

Family Applications (1)

Application Number Title Priority Date Filing Date
GCP199973 GC0000096A (en) 1998-01-30 1999-01-31 Treatment of female sexual dysfunction.

Country Status (34)

Country Link
US (2) US5945117A (sk)
EP (1) EP1056419A4 (sk)
JP (1) JP2002501875A (sk)
KR (1) KR20010040477A (sk)
CN (1) CN1250221C (sk)
AR (1) AR017976A1 (sk)
AU (1) AU752928B2 (sk)
BG (1) BG64667B1 (sk)
BR (1) BR9908038A (sk)
CA (1) CA2322289A1 (sk)
CO (1) CO4970819A1 (sk)
CR (1) CR5959A (sk)
DZ (1) DZ2714A1 (sk)
GC (1) GC0000096A (sk)
GT (1) GT199900013A (sk)
HK (1) HK1040901B (sk)
HN (1) HN1999000015A (sk)
HU (1) HUP0101268A3 (sk)
IL (2) IL137569A0 (sk)
JO (1) JO2085B1 (sk)
MA (1) MA26600A1 (sk)
MX (1) MXPA00007447A (sk)
NO (1) NO319821B1 (sk)
NZ (1) NZ506597A (sk)
PA (1) PA8467801A1 (sk)
PE (1) PE20000240A1 (sk)
PL (1) PL194350B1 (sk)
SK (1) SK11362000A3 (sk)
TN (1) TNSN99008A1 (sk)
TR (1) TR200002220T2 (sk)
TW (1) TW550069B (sk)
UY (1) UY25374A1 (sk)
WO (1) WO1999038467A1 (sk)
ZA (1) ZA99686B (sk)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165122A1 (en) * 1994-04-22 2002-11-07 Heaton Jeremy P. W. Method and compositions for the treatment or amelioration of female sexual dysfunction
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
JP2002518435A (ja) * 1998-06-22 2002-06-25 クイーンズ ユニバーシティ アット キングストン 女性の性機能不全の治療または改善のための方法および組成物
US20050245494A1 (en) * 1999-07-01 2005-11-03 40 J's Llc Methods to treat one or all of the defined etiologies of female sexual dysfunction
US20050070499A1 (en) * 1999-11-08 2005-03-31 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
BR0005797A (pt) * 2000-03-20 2001-10-16 Abbott Lab Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
CA2405419A1 (en) * 2000-04-07 2001-10-18 Tap Pharmaceutical Products Inc. Apomorphine derivatives and methods for their use
DE60131644T2 (de) 2000-05-09 2008-10-30 Nitromed, Inc., Lexington Infrarotthermographie und behandlung von sexuellen dysfunktionen
ATE369868T1 (de) 2000-06-27 2007-09-15 Qualilife Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
US7223406B2 (en) 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
AU2001278981A1 (en) 2000-07-21 2002-02-05 Tom F Lue Prevention and treatment of sexual arousal disorders
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
CN1486183A (zh) 2000-11-15 2004-03-31 ����ҽҩƷ���޹�˾ 使用阿朴吗啡治疗抗抑郁药引发的性功能障碍
CA2429383A1 (en) * 2000-11-22 2002-05-30 Abbott Laboratories Selective dopamine d4 receptor agonists for treating sexual dysfunction
AR032556A1 (es) * 2001-02-08 2003-11-12 Pharmacia Corp Medicamento de accion inmediata para el tratamiento de la disfuncion sexual
KR20050008658A (ko) * 2002-03-19 2005-01-21 마이클 홀릭 아포모르핀의 글리코시드 및 오르토에스테르 글리코시드유도체들, 유사체들 및 그것의 용도
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
GB0221711D0 (en) * 2002-09-19 2002-10-30 Ardana Bioscience Ltd Methods
CA2445212A1 (en) * 2002-10-10 2004-04-10 Queen's University At Kingston Treatment of sexual dysfunction
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
EP1613323A1 (en) * 2003-04-14 2006-01-11 Vectura Limited Pharmaceutical compositions comprising apomorhine for pulmonary inhalation
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
ATE412648T1 (de) * 2005-03-21 2008-11-15 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
US20080214622A1 (en) * 2005-03-21 2008-09-04 Alan Daniel Brown Substituted Triazole Derivatives As Oxytocin Antagonists
WO2006105615A1 (en) * 2005-04-08 2006-10-12 Ozpharma Pty Ltd Buccal delivery system
JP2009504628A (ja) * 2005-08-10 2009-02-05 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
US8349850B2 (en) 2006-03-28 2013-01-08 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US7800094B2 (en) * 2007-06-11 2010-09-21 Macronix International Co., Ltd. Resistance memory with tungsten compound and manufacturing
WO2010144817A1 (en) 2009-06-12 2010-12-16 Adagio Pharmaceuticals Ltd. Sublingual apomorphine
US20130210867A1 (en) * 2010-04-15 2013-08-15 Life Science Enhancement Corporation Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
KR101946774B1 (ko) 2010-12-16 2019-02-11 선오비온 파마슈티컬스 인코포레이티드 설하 필름
US9353067B2 (en) 2011-04-10 2016-05-31 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2545905A1 (en) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited A new therapeutical composition containing apomorphine as active ingredient
JP7211706B2 (ja) 2015-04-21 2023-01-24 サノヴィオン ファーマシュティカルズ インコーポレーテッド 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
JPH07506823A (ja) * 1992-05-18 1995-07-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 記憶障害，性的機能不全およびパーキンソン氏病の治療のためのインドロン誘導体の使用
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
DK0758895T3 (da) * 1994-04-22 2000-06-13 Pentech Pharmaceuticals Inc Sublinguale dosisformer indeholdende apomorphin til anvendelse ved behandling af erektil dysfunktion
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction

Also Published As

Publication number Publication date
PE20000240A1 (es) 2000-03-31
WO1999038467A1 (en) 1999-08-05
SK11362000A3 (sk) 2001-02-12
MXPA00007447A (es) 2006-01-25
HK1040901B (zh) 2006-11-24
EP1056419A4 (en) 2007-05-02
NO20003845D0 (no) 2000-07-27
NO20003845L (no) 2000-09-28
CO4970819A1 (es) 2000-11-07
CN1313742A (zh) 2001-09-19
BG64667B1 (bg) 2005-11-30
PL194350B1 (pl) 2007-05-31
US6193992B1 (en) 2001-02-27
TR200002220T2 (tr) 2000-12-21
AU752928B2 (en) 2002-10-03
JO2085B1 (en) 2000-05-21
MA26600A1 (fr) 2004-12-20
BR9908038A (pt) 2002-01-02
BG104715A (bg) 2001-02-28
AR017976A1 (es) 2001-10-24
ZA99686B (en) 1999-07-28
CN1250221C (zh) 2006-04-12
HK1040901A1 (en) 2002-06-28
UY25374A1 (es) 1999-09-27
HUP0101268A2 (hu) 2001-09-28
JP2002501875A (ja) 2002-01-22
CR5959A (es) 1999-07-28
DZ2714A1 (fr) 2003-09-01
NZ506597A (en) 2003-07-25
IL137569A0 (en) 2001-07-24
GT199900013A (es) 2001-07-20
CA2322289A1 (en) 1999-08-05
EP1056419A1 (en) 2000-12-06
IL137569A (en) 2006-08-01
KR20010040477A (ko) 2001-05-15
PA8467801A1 (es) 2000-09-29
AU2564499A (en) 1999-08-16
TNSN99008A1 (fr) 2005-11-10
TW550069B (en) 2003-09-01
US5945117A (en) 1999-08-31
HN1999000015A (es) 1999-08-23
PL342062A1 (en) 2001-05-21
HUP0101268A3 (en) 2002-12-28
NO319821B1 (no) 2005-09-19

Similar Documents

Publication Publication Date Title
GC0000096A (en) Treatment of female sexual dysfunction.
EP1027057A4 (en) TREATMENT OF FEMALE SEXUAL DISORDERS
IL153492A0 (en) Treatment of male sexual dysfunction
IL141553A0 (en) Drug preparations for treating sexual dysfunction
GB9608408D0 (en) Treatment of erectile dysfunction
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
AU3894600A (en) Method of treating sexual dysfunction
AU3776799A (en) Methods for treating female sexual dysfunction
EP1079764A4 (en) TREATMENT OF SEXUALITY DISORDERS IN CERTAIN GROUPS OF PATIENTS
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
IL155775A0 (en) Treatment of male sexual dysfunction
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
PL362980A1 (en) Treatment of sexual dysfunction
ZA200007396B (en) Method of treatment.
ZA200006375B (en) Compounds for the treatment of female sexual dysfunction.
GB0030647D0 (en) Treatment of male sexual dysfunction
SI1047428T1 (sl) Uporaba morfolinola za zdravljenje seksualne disfunkcije
GB0011926D0 (en) Treatment of sexual dysfunction
ZA994585B (en) Treatment of water.
GB9928178D0 (en) Agent for the treatment of male and female sexual dysfunction
GB0106167D0 (en) Treatment of male sexual dysfunction
GB0120679D0 (en) Treatment of male sexual dysfunction
GB0108730D0 (en) Treatment of male sexual dysfunction
GB0108483D0 (en) Treatment of male sexual dysfunction
GB9813291D0 (en) Sexual dysfunction